475 related articles for article (PubMed ID: 24623107)
21. Anti-candida effect of bacillomycin D-like lipopeptides from Bacillus subtilis B38.
Tabbene O; Kalai L; Ben Slimene I; Karkouch I; Elkahoui S; Gharbi A; Cosette P; Mangoni ML; Jouenne T; Limam F
FEMS Microbiol Lett; 2011 Mar; 316(2):108-14. PubMed ID: 21204933
[TBL] [Abstract][Full Text] [Related]
22. Capability of iturin from Bacillus subtilis to inhibit Candida albicans in vitro and in vivo.
Lei S; Zhao H; Pang B; Qu R; Lian Z; Jiang C; Shao D; Huang Q; Jin M; Shi J
Appl Microbiol Biotechnol; 2019 Jun; 103(11):4377-4392. PubMed ID: 30997554
[TBL] [Abstract][Full Text] [Related]
23. Antiadhesive activity of the biosurfactant pseudofactin II secreted by the Arctic bacterium Pseudomonas fluorescens BD5.
Janek T; Łukaszewicz M; Krasowska A
BMC Microbiol; 2012 Feb; 12():24. PubMed ID: 22360895
[TBL] [Abstract][Full Text] [Related]
24. Biofilm disruption potential of a glycolipid biosurfactant from marine Brevibacterium casei.
Kiran GS; Sabarathnam B; Selvin J
FEMS Immunol Med Microbiol; 2010 Aug; 59(3):432-8. PubMed ID: 20528933
[TBL] [Abstract][Full Text] [Related]
25. Purpurin suppresses Candida albicans biofilm formation and hyphal development.
Tsang PW; Bandara HM; Fong WP
PLoS One; 2012; 7(11):e50866. PubMed ID: 23226409
[TBL] [Abstract][Full Text] [Related]
26. Chemical composition and antifungal activity of Satureja hortensis L. essentiall oil against planktonic and biofilm growth of Candida albicans isolates from buccal lesions of HIV(+) individuals.
Sharifzadeh A; Khosravi AR; Ahmadian S
Microb Pathog; 2016 Jul; 96():1-9. PubMed ID: 27126187
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Candida albicans CC biofilms formation in polystyrene plate surfaces by biosurfactant produced by Trichosporon montevideense CLOA72.
Monteiro AS; Miranda TT; Lula I; Denadai ÂM; Sinisterra RD; Santoro MM; Santos VL
Colloids Surf B Biointerfaces; 2011 Jun; 84(2):467-76. PubMed ID: 21376544
[TBL] [Abstract][Full Text] [Related]
28. Antifungal effects of undecylenic acid on the biofilm formation of Candida albicans.
Shi D; Zhao Y; Yan H; Fu H; Shen Y; Lu G; Mei H; Qiu Y; Li D; Liu W
Int J Clin Pharmacol Ther; 2016 May; 54(5):343-53. PubMed ID: 26902505
[TBL] [Abstract][Full Text] [Related]
29. Zerumbone inhibits
Shin DS; Eom YB
Can J Microbiol; 2019 Oct; 65(10):713-721. PubMed ID: 31158320
[No Abstract] [Full Text] [Related]
30. Anti-biofilm activity of the metabolites of Streptomyces chrestomyceticus strain ADP4 against Candida albicans.
Srivastava V; Dubey AK
J Biosci Bioeng; 2016 Oct; 122(4):434-40. PubMed ID: 27117484
[TBL] [Abstract][Full Text] [Related]
31. BDSF inhibits Candida albicans adherence to urinary catheters.
Tian J; Weng LX; Zhang YQ; Wang LH
Microb Pathog; 2013 Nov; 64():33-8. PubMed ID: 23948468
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Candida albicans biofilm formation and yeast-hyphal transition by 4-hydroxycordoin.
Messier C; Epifano F; Genovese S; Grenier D
Phytomedicine; 2011 Mar; 18(5):380-3. PubMed ID: 21353508
[TBL] [Abstract][Full Text] [Related]
33. Terpenoids of plant origin inhibit morphogenesis, adhesion, and biofilm formation by Candida albicans.
Raut JS; Shinde RB; Chauhan NM; Karuppayil SM
Biofouling; 2013; 29(1):87-96. PubMed ID: 23216018
[TBL] [Abstract][Full Text] [Related]
34. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans.
Messier C; Grenier D
Mycoses; 2011 Nov; 54(6):e801-6. PubMed ID: 21615543
[TBL] [Abstract][Full Text] [Related]
35. Iturin A is the principal inhibitor in the biocontrol activity of Bacillus amyloliquefaciens PPCB004 against postharvest fungal pathogens.
Arrebola E; Jacobs R; Korsten L
J Appl Microbiol; 2010 Feb; 108(2):386-95. PubMed ID: 19674188
[TBL] [Abstract][Full Text] [Related]
36. Disinfectant-like activity of lipopeptide biosurfactant produced by Bacillus tequilensis strain SDS21.
Singh AK; Sharma P
Colloids Surf B Biointerfaces; 2020 Jan; 185():110514. PubMed ID: 31639569
[TBL] [Abstract][Full Text] [Related]
37. Anti-adhesion activity of two biosurfactants produced by Bacillus spp. prevents biofilm formation of human bacterial pathogens.
Rivardo F; Turner RJ; Allegrone G; Ceri H; Martinotti MG
Appl Microbiol Biotechnol; 2009 Jun; 83(3):541-53. PubMed ID: 19343338
[TBL] [Abstract][Full Text] [Related]
38. Functions of lipopeptides bacillomycin D and fengycin in antagonism of Bacillus amyloliquefaciens C06 towards Monilinia fructicola.
Liu J; Zhou T; He D; Li XZ; Wu H; Liu W; Gao X
J Mol Microbiol Biotechnol; 2011; 20(1):43-52. PubMed ID: 21335978
[TBL] [Abstract][Full Text] [Related]
39. Lipopeptides from Bacillus amyloliquefaciens strain 32a as promising biocontrol compounds against the plant pathogen Agrobacterium tumefaciens.
Abdallah DB; Tounsi S; Gharsallah H; Hammami A; Frikha-Gargouri O
Environ Sci Pollut Res Int; 2018 Dec; 25(36):36518-36529. PubMed ID: 30374716
[TBL] [Abstract][Full Text] [Related]
40. Minocycline Inhibits Candida albicans Budded-to-Hyphal-Form Transition and Biofilm Formation.
Kurakado S; Takatori K; Sugita T
Jpn J Infect Dis; 2017 Sep; 70(5):490-494. PubMed ID: 28367877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
